About Cusak Pharma Private Limited
Data last updated:
Cusak Pharma Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 06 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24299RJ2018PTC062958. Its GSTIN is 08AAHCC8506F1ZO (Rajasthan).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Suman Rani and Rajrani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 2 Near Kubergarh Resort Chopasni Road Chopasni Village, Jodhpur, Rajasthan, India – 342001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.12 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹12.44 Lakh (net margin 5.9%) and EBITDA of ₹25.01 Lakh (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 34% over five years.
As per MCA filings, the company has open charges of ₹13.87 Lakh on record.
For more details, the company can be reached via its website cusakpharma.co.uk.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No. 2 Near Kubergarh Resort Chopasni Road Chopasni Village, Jodhpur, Rajasthan, India – 342001
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cusak Pharma Private Limited
The main business activity of Cusak Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cusak Pharma Private Limited FY 2025 filings available
Cusak Pharma Private Limited reported revenue of ₹2.12 Cr (up 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Cusak Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 41% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cusak Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25.01 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.44 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cusak Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cusak Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cusak Pharma Private Limited
Cusak Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Garnet Powertech Private Limted | ₹2.12 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Delhi, India |
| Alna Trading and Exports Limited Listed | ₹2.12 Cr (FY 2025) | •••• | •••• | 123.0% | •••• | Mumbai, Maharashtra, India |
| Nympheas Solutions Private Limited | ₹2.12 Cr (FY 2018) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Red Cherry Fashion & Accessories Private Limited | ₹2.12 Cr (FY 2019) | •••• | •••• | -96.0% | •••• | Mumbai, Maharashtra, India |
| JD Mercantile Private Limited | ₹2.12 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Cusak Pharma Private Limited this company | ₹2.12 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Jodhpur, Rajasthan, India |
| Marksvnt P. Industries Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 127.0% | •••• | Dewas, Madhya Pradesh, India |
| Ebc Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Thrissur, Kerala, India |
| Superpower Lubricants Private Limited | ₹2.12 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | New Delhi, Delhi, India |
| Antrix Electrotech Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Kanpur, Uttar Pradesh, India |
| S. R. Saree Emporium Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | -37.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Cusak Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Cusak Pharma Private Limited
Cusak Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Rani | Director | 06 Nov 2018 | 7 Years 11 Months | Current |
| Rajrani | Director | 06 Nov 2018 | 7 Years 11 Months | Current |
| Sourabh Gandhi | Director | 25 Nov 2019 | 6 Years 10 Months | Current |
Ownership and Shareholding of Cusak Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cusak Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Apr 2023 | Hdfc Bank Limited | ₹13.87 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Cusak Pharma Private Limited
Employment history and EPFO contributions of people linked to Cusak Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cusak Pharma Private Limited
Cusak Pharma Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Sourabh Gandhi ceased to be Additional Director on 31 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Cusak Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cusak Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cusak Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cusak Pharma Private Limited
Cusak Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCC8506F1ZO | Rajasthan | Active | 04 Dec 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cusak Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cusak Pharma Private Limited
Cusak Pharma is an active private limited company based in Jodhpur, Rajasthan, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 06 November 2018 (8+ years old) and is registered under CIN U24299RJ2018PTC062958.
Cusak Pharma reported revenue of ₹2.12 Cr for FY 2025 (up 41% YoY).
Cusak Pharma has 3 current directors:
- Suman Rani - Director
- Rajrani - Director
- Sourabh Gandhi - Director
Cusak Pharma reported a net profit of ₹12.44 Lakh (net margin 5.9%) and EBITDA of ₹25.01 Lakh (EBITDA margin 11.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cusak Pharma is 35% over three years and 34% over five years. In the latest year (FY 2025) revenue rose 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cusak Pharma is 08AAHCC8506F1ZO, registered in Rajasthan.
The CIN (Corporate Identification Number) of Cusak Pharma is U24299RJ2018PTC062958. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cusak Pharma was incorporated on 06 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Cusak Pharma by revenue are Garnet Powertech Private Limted, Alna Trading and Exports Limited, Nympheas Solutions Private Limited, Red Cherry Fashion & Accessories Private Limited, JD Mercantile Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Sourabh Gandhi ceased to be Additional Director on 31 Dec 2019. Sourabh Gandhi was appointed as Director on 25 Nov 2019. Rajrani was appointed as Director on 06 Nov 2018. Cusak Pharma has 4 board changes on record in total.
Cusak Pharma can be reached through the website cusakpharma.co.uk. Its registered office is in Jodhpur, Rajasthan, India.